1. Home
  2. WFG vs TMDX Comparison

WFG vs TMDX Comparison

Compare WFG & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo West Fraser Timber Co. Ltd.

WFG

West Fraser Timber Co. Ltd.

N/A

Current Price

$63.50

Market Cap

5.2B

Sector

N/A

ML Signal

N/A

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

N/A

Current Price

$121.40

Market Cap

4.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WFG
TMDX
Founded
1955
1998
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
4.6B
IPO Year
2007
2019

Fundamental Metrics

Financial Performance
Metric
WFG
TMDX
Price
$63.50
$121.40
Analyst Decision
Strong Buy
Buy
Analyst Count
2
9
Target Price
$89.50
$154.00
AVG Volume (30 Days)
205.8K
791.1K
Earning Date
01-01-0001
06-01-2026
Dividend Yield
1.99%
N/A
EPS Growth
N/A
382.18
EPS
N/A
4.87
Revenue
N/A
$605,494,000.00
Revenue This Year
$5.36
$24.12
Revenue Next Year
$10.63
$18.69
P/E Ratio
N/A
$26.48
Revenue Growth
N/A
37.13
52 Week Low
$57.34
$62.42
52 Week High
$79.22
$156.00

Technical Indicators

Market Signals
Indicator
WFG
TMDX
Relative Strength Index (RSI) 32.99 36.81
Support Level $62.81 $106.27
Resistance Level $76.61 $128.96
Average True Range (ATR) 1.84 8.92
MACD -0.41 -1.90
Stochastic Oscillator 12.37 0.30

Price Performance

Historical Comparison
WFG
TMDX

About WFG West Fraser Timber Co. Ltd.

West Fraser Timber is a softwood lumber company that also produces wood panels and pulp products. The company produces its wood products globally, with lumber mills in British Columbia, Alberta, Europe, and the Southeastern United States. Following its acquisition of Norbord in 2021, West Fraser is one of the largest oriented strand board producers in the world.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: